REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sichuan Goldstone Asia Pharmaceutical Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Plastics Pipe and Pipe Fitting Manufacturing
Full name: Sichuan Goldstone Asia Pharmaceutical Inc. Profile Updated: April 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Sichuan Goldstone Asia Pharmaceutical Inc. is mainly engaged in research, development, manufacture and sale of pharmaceuticals, health products, steel reinforced plastic composite pipes and pipe fittings. The company was founded in 2004 and is headquartered in Chengdu City, China.

Headquarters
Company Headquarters: 8th Floor, A1 District, Dadi New Guanghua Plaza, No. 8 Jiayuan Road, Qingyang District, Chengdu, Sichuan Province; Hangzhou Office: Asia Science Center, No. 4760, Jiangnan Avenue, Binjiang District, Hangzhou
Chengdu; Sichuan; Postal Code: 610072

Contact Details: Purchase the Sichuan Goldstone Asia Pharmaceutical Inc. report to view the information.

Website: http://www.goldstone-group.com

Basic Information
Total Employees:
Purchase the Sichuan Goldstone Asia Pharmaceutical Inc. report to view the information.
Outstanding Shares:
Purchase the Sichuan Goldstone Asia Pharmaceutical Inc. report to view the information.
Registered Capital:
Purchase the Sichuan Goldstone Asia Pharmaceutical Inc. report to view the information.
Financial Auditors:
Purchase the Sichuan Goldstone Asia Pharmaceutical Inc. report to view the information.
Incorporation Date:
July 15, 2004
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
25.11%
Purchase this report to view the information.
13.59%
Purchase this report to view the information.
3.64%
Purchase this report to view the information.
3.63%
Purchase this report to view the information.
2.03%
Subsidiaries
Hainan Asia Pharmaceutical Co., Ltd.
100%
Hainan Quick Pharmaceutical Co., Ltd.
100%
Hangzhou Biomedical Technology Pioneer Park Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Sichuan Goldstone Asia Pharmaceutical Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
16.25%▲
Total operating revenue
15.9%▲
Operating profit (EBIT)
33.7%▲
EBITDA
31.31%▲
Net Profit (Loss) for the Period
30.49%▲
Total assets
14.31%▲
Total equity
11.15%▲
Operating Profit Margin (ROS)
2.71%▲
Net Profit Margin
1.78%▲
Return on Equity (ROE)
0.83%▲
Debt to Equity Ratio
-0.05%▼
Quick Ratio
0.26%▲
Cash Ratio
0.58%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Hubei Biocause Pharmaceutical Co.,Ltd.
 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
Zhejiang Hugeleaf Co.,Ltd.
 
Guizhou Sanli Pharmaceutical Co.,Ltd
Pulike Biological Engineering,Inc.
 
Chengdu Easton Bio Pharmaceuticals Co.,Ltd
Zhejiang East-Asia Pharmaceutical Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo